BDTXNasdaq

Black Diamond Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · CIK 1701541

Developing MasterKey therapies targeting families of oncogenic mutations in cancer patients

$100M

Market cap

$1.85

Last close

+5.7%

+14.9%

1.9M

Volume

Price · last 40 sessions-31.5%

May 4L $1.61 · H $3.60Jun 30

116

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance